an-ex-vivo-model-ovarian-cancer-peritoneal-metastasis-using-human

An <em>Ex Vivo</em> Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

Ovarian cancer is the deadliest gynecologic malignancy. The omentum plays a key role in providing a supportive microenvironment to metastatic ovarian ...

Wayne State University School of Medicine

Anoikis is a type of programmed cell death triggered by the loss of cellular interaction with the extracellular matrix (ECM) and culminates in the activation of caspases. Specific interaction between cellular receptors such as integrins and the ECM is important to maintain cellular homeostasis in normal tissues through multiple cascades. This interaction provides not only physical attachment, but more importantly, vital interaction with the actin cytoskeleton and growth factors. Normal epithelial and endothelial cells require this interaction with ECM to survive. In cancer, the acquisition of anoikis resistance is a hallmark of malignant transformation and is required in the process of metastasis formation. As such, strategies to inhibit and/or counteract anoikis resistance are important in controlling cancer progression. In this chapter, we describe the method for detecting anoikis using cell viability and caspase activity assays.

Detection of Anoikis Using Cell Viability Dye and Quantitation of Caspase Activity.

Ovarian cancer recurs in most High Grade Serous Ovarian Cancer (HGSOC) patients, including initial responders, after standard of care. To improve patient survival, we need to identify and understand the factors contributing to early or late recurrence and therapeutically target these mechanisms. We hypothesized that in HGSOC, the response to chemotherapy is associated with a specific gene expression signature determined by the tumor microenvironment. In this study, we sought to determine the differences in gene expression and the tumor immune microenvironment between patients who show early recurrence (within 6 months) compared to those who show late recurrence following chemotherapy.

Roslyn Tedja

C.S. Mott Center for Human Growth and Development,
Department of Obstetrics and Gynecology,
C.S. Mott Center for Human Growth and Development, Department of Obstetrics and Gynecology

Wayne State University School of Medicine

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

Roslyn Tedja

C.S. Mott Center for Human Growth and Development,Department of Obstetrics and Gynecology,C.S. Mott Center for Human Growth and Development, Department of Obstetrics and Gynecology

Wayne State University School of Medicine

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

C.S. Mott Center for Human Growth and Development,
Department of Obstetrics and Gynecology,
C.S. Mott Center for Human Growth and Development, Department of Obstetrics and Gynecology